Germ-line BRCA1 Mutations in Selected Men with Prostate Cancer

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 1996 Apr 1

PMID 8644752

Citations 6

Authors

A A Langston

J L Stanford

K G Wicklund

J D Thompson

R G Blazej

E A Ostrander

Affiliations

Soon will be listed here.

Citing Articles

The 2013 Genetics Society of America Medal: Elaine A. Ostrander.

Schimenti J, Halpern M Genetics. 2013; 194(1):5-7.

PMID: 23633134 PMC: 3632481. DOI: 10.1534/genetics.113.150672.

Risks of cancer due to a single BRCA1 mutation in an extended Utah kindred.

Vogl F, Badzioch M, Steele L, Neuhausen S, Goldgar D Fam Cancer. 2006; 6(1):63-71.

PMID: 17051349 DOI: 10.1007/s10689-006-9106-8.

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.

Vazina A, Baniel J, Yaacobi Y, Shtriker A, Engelstein D, Leibovitz I Br J Cancer. 2000; 83(4):463-6.

PMID: 10945492 PMC: 2374645. DOI: 10.1054/bjoc.2000.1249.

Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.

Nastiuk K, Mansukhani M, Terry M, Kularatne P, Rubin M, Melamed J Prostate. 1999; 40(3):172-7.

PMID: 10398279 PMC: 4196372. DOI: 10.1002/(sici)1097-0045(19990801)40:3<172::aid-pros5>3.0.co;2-r.

The 12 base pair duplication/insertion alteration could be a regulatory mutation.

Robledo M, Osorio A, Sentis C, Albertos J, Estevez L, Benitez J J Med Genet. 1997; 34(7):592-3.

PMID: 9222971 PMC: 1051003. DOI: 10.1136/jmg.34.7.592.

References

Struewing J, Brody L, Erdos M, Kase R, Giambarresi T, Smith S . Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet. 1995; 57(1):1-7. PMC: 1801253. View

Takahashi H, Behbakht K, McGovern P, Chiu H, Couch F, Weber B . Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res. 1995; 55(14):2998-3002. View

ISAACS S, Kiemeney L, Baffoe-Bonnie A, Beaty T, Walsh P . Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst. 1995; 87(13):991-6. DOI: 10.1093/jnci/87.13.991. View

Struewing J, Abeliovich D, Peretz T, Avishai N, Kaback M, Collins F . The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet. 1995; 11(2):198-200. DOI: 10.1038/ng1095-198. View

Ford D, Easton D, Peto J . Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet. 1995; 57(6):1457-62. PMC: 1801430. View

Langston A, Malone K, Thompson J, Daling J, Ostrander E . BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med. 1996; 334(3):137-42. DOI: 10.1056/NEJM199601183340301. View

Anderson D, Badzioch M . Familial breast cancer risks. Effects of prostate and other cancers. Cancer. 1993; 72(1):114-9. DOI: 10.1002/1097-0142(19930701)72:1<114::aid-cncr2820720122>3.0.co;2-0. View

Thiessen E . Concerning a familial association between breast cancer and both prostatic and uterine malignancies. Cancer. 1974; 34(4):1102-7. DOI: 10.1002/1097-0142(197410)34:4<1102::aid-cncr2820340421>3.0.co;2-5. View

Harlow B, Davis S . Two one-step methods for household screening and interviewing using random digit dialing. Am J Epidemiol. 1988; 127(4):857-63. DOI: 10.1093/oxfordjournals.aje.a114869. View

10.

Hall J, Lee M, Newman B, MORROW J, Anderson L, Huey B . Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990; 250(4988):1684-9. DOI: 10.1126/science.2270482. View

11.

Carter B, Beaty T, Steinberg G, Childs B, Walsh P . Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A. 1992; 89(8):3367-71. PMC: 48868. DOI: 10.1073/pnas.89.8.3367. View

12.

Anderson D, Badzioch M . Breast cancer risks in relatives of male breast cancer patients. J Natl Cancer Inst. 1992; 84(14):1114-7. DOI: 10.1093/jnci/84.14.1114. View

13.

Tulinius H, Egilsson V, Olafsdottir G, Sigvaldason H . Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. BMJ. 1992; 305(6858):855-7. PMC: 1883041. DOI: 10.1136/bmj.305.6858.855. View

14.

Arason A, Barkardottir R, Egilsson V . Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. Am J Hum Genet. 1993; 52(4):711-7. PMC: 1682066. View

15.

Ford D, Easton D, Bishop D, Narod S, Goldgar D . Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet. 1994; 343(8899):692-5. DOI: 10.1016/s0140-6736(94)91578-4. View

16.

Miki Y, Swensen J, Futreal P, Harshman K, Tavtigian S, Liu Q . A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994; 266(5182):66-71. DOI: 10.1126/science.7545954. View

17.

Sellers T, Potter J, Rich S, Drinkard C, Bostick R, Kushi L . Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J Natl Cancer Inst. 1994; 86(24):1860-5. DOI: 10.1093/jnci/86.24.1860. View

18.

Easton D, Ford D, Bishop D . Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995; 56(1):265-71. PMC: 1801337. View

19.

McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K . A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA. 1995; 273(7):535-41. View

20.

Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S . Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet. 1994; 8(4):392-8. DOI: 10.1038/ng1294-392. View